Monsanto to drop all requests for new GM crops in EU

The following is an edited excerpt.

US seed producer Monsanto has said it would withdraw all new requests to grow genetically modified crops in the EU. The move reflects its frustration over ongoing resistance to GM crops among populations in Europe.

All approval requests for new types of genetically modified (GM) crops filed with the European Union would be stopped within the next few months, Monsanto President and Managing Director for Europe Jose Manuel Madero told British news agency Reuters on Wednesday.

The withdrawal would affect requests for growing genetically modified maize, one soybean and one sugar beet, Madero was quoted as saying.

The move was prompted by a lack of commercial prospects for cultivating GMOs (genetically modified organisms) in the 28-nation bloc, and came as the US-based company was re-focusing on its conventional seeds business in Europe, Madero added.

Read the full story here: Monsanto to drop all requests for new GM crops in EU

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-05-at-2.12.30-PM
Some plants can poison you. So how did humans figure out what is safe to eat?
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
ChatGPT-Image-May-18-2026-12_06_18-PM-2
Defying death: The immortality movement goes mainstream

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.